Evogene (EVGN) Total Non-Current Liabilities (2016 - 2025)

Evogene has disclosed Total Non-Current Liabilities across 10 years of filings, most recently posting $4.6 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 26.92% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (down 26.92% YoY), while the FY2025 annual figure was $4.6 million, down 26.92% from the prior year.
• Total Non-Current Liabilities came in at $4.6 million for Q4 2025 at Evogene, down from $6.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $15.8 million in Q2 2023 to a low of $4.6 million in Q4 2025.
• Average Total Non-Current Liabilities over 5 years is $8.6 million, with a median of $6.2 million recorded in 2021.
• Year-over-year, Total Non-Current Liabilities jumped 176.73% in 2023 and sank 70.06% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $6.0 million in 2021, then soared by 161.76% to $15.7 million in 2022, then slipped by 1.52% to $15.5 million in 2023, then slumped by 59.08% to $6.3 million in 2024, then declined by 26.92% to $4.6 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $4.6 million in Q4 2025, $6.4 million in Q2 2025, and $6.3 million in Q4 2024.